MIAMI / Jul 16, 2024 / Business Wire / Ontrak, Inc (NASDAQ: OTRK), a leading AI-powered and technology-enabled behavioral healthcare company, announces the adoption of the Comprehensive Healthcare Integration (CHI) framework into its care delivery model. This advances Ontrak Health’s commitment to delivering high quality, integrated, whole person care. The CHI model represents the most comprehensive clinical framework for integrating physical health, behavioral health, and social determinants of health within care delivery.
Developed by the National Council for Mental Wellbeing in 2022, the CHI framework provides a robust foundation for implementing and measuring the progress of integrated healthcare services. The CHI white paper explains, “The evidence strongly suggests that people of all ages living with co-occurring PH, BH and SDOH needs have higher health costs yet experience poorer health outcomes. Emerging evidence suggests that more coordinated or integrated oral, mental health and substance use treatment services can increase access to needed care, improve patient outcomes and potentially reduce healthcare costs. The evidence further suggests that populations with co-occurring PH, BH and SDOH needs are likely to benefit from evidence-based integrated interventions in whatever setting they are best engaged, with more complex and high-cost populations generally requiring higher levels of service intensity.”
"With the adoption of the CHI framework we are unlocking the full potential of integrated care through our clinical programs," said Dr. Judith Feld, Chief Medical Officer of Ontrak Health. "We are proud to champion the evolution of care delivery, harnessing the power of integrated care to improve patient lives."
The eight domains of the CHI framework, and the ways in which Ontrak Health applies them to its programs, include:
The adoption of the CHI framework underscores Ontrak Health's commitment to addressing the complex interplay of physical health, behavioral health, and social determinants of health. Our results speak volumes: a guaranteed 2.0x ROI, 62% reduction in inpatient utilization, 32% decrease in ER visits, and 28% net cost savings. These outcomes, coupled with clinically significant improvements in GAD-7 and PHQ-9 scores of 53% and 62% respectively, and an NPS of 68, demonstrate that Ontrak is at the forefront of translating the promise of integrated care into tangible benefits for our members and partners. We're not just implementing a framework; we're pioneering a more effective, equitable, and sustainable approach to healthcare delivery.
About Ontrak Health
Ontrak Health (Nasdaq: OTRK) is a leading AI and technology-enabled behavioral healthcare company, whose mission is to help improve the health and save the lives of as many people as possible. Ontrak identifies, engages, activates, and provides care pathways to treatment for the most vulnerable members of the behavioral health population who would otherwise fall through the cracks of the healthcare system. We engage individuals with anxiety, depression, substance use disorder and chronic disease through personalized care coaching and customized care pathways that help them receive the treatment and advocacy they need, despite the socio-economic, medical and health system barriers that exacerbate the severity of their comorbid illnesses. The company’s integrated intervention platform uses AI, predictive analytics and digital interfaces combined with dozens of care coach engagements to deliver improved member health, better healthcare system utilization, and durable outcomes and savings to healthcare payors.
Last Trade: | US$1.73 |
Daily Change: | -0.05 -2.81 |
Daily Volume: | 39,790 |
Market Cap: | US$5.540M |
November 13, 2024 November 06, 2024 September 11, 2024 September 05, 2024 August 29, 2024 |
Terns Pharmaceuticals is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline contains three clinical stage development programs including GLP-1 receptor...
CLICK TO LEARN MOREAmneal Pharmaceuticals is a fully-integrated essential medicines company. We make healthy possible through the development, manufacturing, and distribution of generic and specialty pharmaceuticals. The Company has a diverse portfolio of over 250 products in its Generics segment and is expanding across...
CLICK TO LEARN MOREEnd of content
No more pages to load
COPYRIGHT ©2023 HEALTH STOCKS HUB